PRODUCTS IN DEVELOPMENT

SymphonyTM Biomaker Detection Platform

Bluejay Diagnostics is pleased to present the Symphony biomarker detection platform. The system aims to help improve healthcare outcomes by detecting and preventing cytokine-driven health scares early on.

Symphony is an innovative implementation of the traditionally reliable ELISA methodology combined with modern advances in nanotechnology. The unique design features a combination of microfluidics and interrupted fluid dynamics to offer a fast, simple, safe, and highly sensitive biomarker detection platform.


TECHNOLOGY PLATFORM

Bluejay’s proprietary platform technology is based on a combination of well-established immunochromatography and laminar flow methodologies.


About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc. is developing easy-to-use, point-of-care medical diagnostics tests.



NEWS

Dec 14, 2020

BLUEJAY DIAGNOSTICS, INC. ANNOUNCES COLLABORATION AGREEMENT WITH TORAY INDUSTRIES, INC. TO DEVELOP POINT OF CARE TEST FOR COVID-19 PATIENT TRIAGE

Collaboration focused on developing point of care diagnostic test to quantify IL-6 in whole blood. Acton, MA, Dec 8, 2020 – Bluejay Diagnostics, Inc. (Bluejay, Acton, MA) today announced a collaboration agreement with Toray Industries, Inc. (Toray, Tokyo, Japan) to develop a minimally-invasive, point-of-care test for COVID-19 patients to assess progression of the disease. Symphony™ IL-6 is the first of many products to be developed…